DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Is LAXMI DENTAL LIMITED or TORRENT PHARMACEUTICALS L a better stock to buy?

LAXMI DENTAL LIMITED (LAXMIDENTL), TORRENT PHARMACEUTICALS L (TORNTPHARM) are compared on DocStoX across valuation, profitability, growth and financial health. On P/E: LAXMI DENTAL LIMITED at 36.9, TORRENT PHARMACEUTICALS L at 77.9. On ROE: LAXMI DENTAL LIMITED at 14.8%, TORRENT PHARMACEUTICALS L at 27.4%. The better pick depends on whether you prioritise valuation, growth or balance-sheet strength.

LAXMI DENTAL LIMITED vs TORRENT PHARMACEUTICALS L: which has the lowest PE ratio?

LAXMI DENTAL LIMITED has the lowest PE ratio — LAXMI DENTAL LIMITED is at 36.9, TORRENT PHARMACEUTICALS L is at 77.9. A lower PE can signal a cheaper valuation, though it must be read alongside growth and quality.

Which is bigger, LAXMI DENTAL LIMITED or TORRENT PHARMACEUTICALS L?

TORRENT PHARMACEUTICALS L is the largest by market capitalisation — LAXMI DENTAL LIMITED is ₹1,069 crore, TORRENT PHARMACEUTICALS L is ₹1,89,918 crore.

LAXMI DENTAL LIMITED vs TORRENT PHARMACEUTICALS L

A side-by-side comparison of LAXMI DENTAL LIMITED (LAXMIDENTL) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

LAXMI DENTAL LIMITED

LAXMIDENTL

₹194.33+0.72%

TORRENT PHARMACEUTICALS L

TORNTPHARM

₹4,980.5+0.30%

Leads on the numbers

The verdict

On the numbers, TORRENT PHARMACEUTICALS L leads LAXMIDENTL vs TORNTPHARM on 8 of 14 metrics (2 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation22
Profitability03
Growth10
Size & financial health13

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

36.87

P/E ratio

77.92

5.07

P/B ratio

18.67

0.00%

Dividend yield

0.76%

₹5.27

EPS

₹63.92

Profitability

TORNTPHARM takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

14.80%

Return on equity

27.40%

15.00%

Return on capital even

15.00%

16.00%

EBITDA margin

33.00%

10.43%

Net margin

15.29%

Growth

LAXMIDENTL takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

19.72%

Revenue CAGR (3Y)

13.27%

—

Profit CAGR (3Y) even

19.75%

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1,069 Cr

Market cap

₹1.90L Cr

₹278 Cr

Revenue

₹13,980 Cr

₹29 Cr

Net profit

₹2,138 Cr

0.04

Debt / equity

1.69

LAXMI DENTAL LIMITED

+ ["Company has reduced debt.", "Company is almost debt free.", "Company has delivered good profit growth of 103% CAGR over last 5 years"]

− ["Though the company is reporting repeated profits, it is not paying out dividend", "Tax rate seems low", "Working capital days have increased from 77.3 days to 195 days"]

TORRENT PHARMACEUTICALS L

+ ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]

− ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]

LAXMI DENTAL LIMITED full analysis TORRENT PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.